United States · Funded startup

Who invested in Context Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$100Mraised across 1 round since 2024, from 1 source

Latest round
Round, $100MMay 2024
Investors
2
See who backed them

The rounds

  1. May 2024
    Round$100M

    Source recordedSEC filing: $100M sold, first sale May 2024

Founders and team

From Context Therapeutics's own website and the SEC filings it signed: 8 on the team.

  • Martin Albert LehrChief Executive Officer
  • Andy PasternakChairman, Independent Director
  • Erin ZebrowskiDirector, Clinical Sciences
  • Jorie WestSenior Director of Program Management
  • Mary SpharExecutive Assistant & Office Manager
  • Alex Albert LevitExecutive Officeri
  • Jennifer Albert Minai-AzaryExecutive Officeri
  • Linda Beth WestIndependent Director

On the board, as filediJennifer Beth Evans StaceyPhilip Jay KantoffRichard Jay Berman

Everyone who backed them

Blackstone GroupPrivate equity1round
Blue OwlAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Context Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Nextech InvestPrivate equityPer its own site

Quick answers about Context Therapeutics

Who invested in Context Therapeutics?

Context Therapeutics's investors include Blackstone Group and Blue Owl.

How much has Context Therapeutics raised?

Context Therapeutics has raised $100M across 1 round since 2024.

When did Context Therapeutics last raise?

Context Therapeutics's most recent round was an Undisclosed round of $100M in May 2024.

What was Context Therapeutics's biggest round?

Its most recent round, $100M in May 2024, is also its largest on record.

Who backed Context Therapeutics first?

Context Therapeutics's first round on record, in May 2024, was backed by Blackstone Group and Blue Owl.

What stage is Context Therapeutics at?

Context Therapeutics's latest named round is an Undisclosed round, in May 2024.

Where is Context Therapeutics based?

Context Therapeutics is based in the United States.

Companies like Context Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.